Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost recent
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

FDA approves first mRNA flu vaccine for adults 50+

Digest more
Top News
Overview
Science News · 2d
Here’s what the first mRNA flu vaccine could mean for flu season
mRNA flu shots have officially arrived. On August 5, the U.S. Food and Drug Administration approved the first influenza vaccine that uses the same technology underpinning COVID-19 shots.

Continue reading

Tech Times on MSN · 3d
mRNA flu vaccine faces FDA verdict: Approval alone won't mean coverage for seniors
 · 2d
World's First mRNA Flu Vaccine For Older Adults, mFlusiva, Approved By US Drug Regulator
 · 20h
The new mRNA flu shot mFlusiva is more effective. Why doctors worry Long Islanders may not get it.
A newly approved flu vaccine that studies show is more effective than others may be in Long Island pharmacies in the coming weeks, but the mRNA technology it uses may unnecessarily scare some people a...

Continue reading

 · 1d
The flu shot is about to change forever. Here’s why.
 · 1d
Moderna mRNA flu shot wins FDA approval but awaits CDC recommendations
1d

First mRNA flu shot approved by FDA bodes well for improving drugs of the future – though a few hurdles remain before mRNA can move beyond vaccines

From COVID-19 vaccines to Moderna’s mRNA flu vaccine, using mRNA as medicine has shown promise. But before mRNA drugs can go beyond vaccines, researchers need to identify the right diseases to treat.
Forbes
2mon

New Study Shows How mRNA Vaccines Could Transform Cancer Treatment

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Malignant melanoma (cancer of the skin or mucous membranes), developed at the expense of melanocytes (melanocytic tumor). (Photo by: CAVALLINI ...
Tech Times on MSN
4d

Moderna's mRNA Ebola vaccine enters human trials: Platform speed meets cold-chain wall in Ituri

Moderna mRNA Ebola vaccine mRNA-1469 entered Phase 1 trials in Canada on August 4, 2026 — making Canada the second country, after the UK, to test a Bundibugyo-specific shot. The mRNA platform's cold-chain requirement means it cannot reach Ituri Province,
  • Privacy
  • Terms